Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.

Hirai, Fumihiko; Seto, Takashi; Yamanaka, Takeharu; Toyozawa, Ryo; Inamasu, Eiko; Kojo, Miyako; Toyokawa, Gouji; Morodomi, Yosuke; Shiraishi, Yoshimasa; Takenaka, Tomoyoshi; Yamaguchi, Masafumi; Takenoyama, Mitsuhiro; Ichinose, Yukito

Hirai, Fumihiko; Seto, Takashi; Yamanaka, Takeharu; Toyozawa, Ryo; Inamasu, Eiko; Kojo, Miyako; Toyokawa, Gouji; Morodomi, Yosuke; Shiraishi, Yoshimasa; Takenaka, Tomoyoshi; Yamaguchi, Masafumi; Takenoyama, Mitsuhiro; Ichinose, Yukito.

Affiliation

Hirai F; *Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka 811-1395, Japan. tseto@nk-cc.gp.jp.

Jpn J Clin Oncol ; 43(10): 1018-22, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23917962

Subject(s)

Anthracyclines/therapeutic use; Antibiotics, Antineoplastic/therapeutic use; Thymoma/drug therapy; Thymus Neoplasms/drug therapy; Adenocarcinoma/drug therapy; Aged; Anthracyclines/administration & dosage; Antibiotics, Antineoplastic/administration & dosage; Antineoplastic Agents/therapeutic use; Carcinoma, Small Cell/drug therapy; Carcinoma, Squamous Cell/drug therapy; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Platinum Compounds/therapeutic use; Retrospective Studies; Thymoma/pathology; Thymus Neoplasms/pathology; Treatment Outcome

Key words

amrubicin; second-line chemotherapy; thymic cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms / Anthracyclines / Antibiotics, Antineoplastic Type of study: Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 2013 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google